{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for glutathione root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT02129075: Phase 2 Interventional Completed Cutaneous Melanoma
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03526835: Phase 1/Phase 2 Interventional Recruiting Advanced/Metastatic Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ozuriftamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:volrustomig [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nivisnebart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sovipostobart beta [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ivonescimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:iparomlimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tabituximab barzuxetan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04286438: Phase 3 Interventional Completed Hemorrhage
(2020)
Source URL:
Class:
PROTEIN